Managing patients with high Lp(a) | Peter Attia, M.D. & Benoît Arsenault, Ph.D.

Well SupportedNewborn babies have ApoB levels below 20 mg/dL without any negative health consequences, indicating that very low ApoB levels are not detrimental.

Partially SupportedPeter Attia uses PCSK9 inhibitors liberally in his practice, believing that even a 30% reduction in Lp(a) is worthwhile until antisense oligonucleotides are available.

Partially SupportedPeter Attia's Lp(a) level is 200 nanomolar, and he has started taking a statin to aggressively lower LDL early.

Partially SupportedIndividuals with high Lp(a) should consider starting a statin, potentially increasing the dose if LDL levels do not decrease sufficiently.